Moreover, although meta-analytic findings indicate improvements in inflammatory markers such as CRP, IL-6, TNF-α, and MDA, there remain inconsistencies across individual studies, particularly regarding the magnitude and durability of these effects, as well as their relevance to long-term T2DM outcomes. This evidence concerns the gene TNF and type 2 diabetes mellitus.